Cytokine profile in HTB-4 cells with respect to fimH, papC and hlyA expression in uropathogenic Escherichia coli invasion

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Bien J, Sokolova O, Bozko P. Role of uropathogenic Escherichia coli virulence factors in development of urinary tract infection and kidney damage. Intl J. Nephrol. 2012, 1–15 (2012).
  Google Scholar
• 2. Habak PJ, Griggs J. Urinary tract infection in pregnancy. In: StatPearls. StatPearls Publishing, FL, USA (2022).
  Google Scholar
• 3. Konwar M, Gogtay NJ, Ravi R, Thatte UM, Bose D. Evaluation of efficacy and safety of fosfomycin versus nitrofurantoin for the treatment of uncomplicated lower urinary tract infection (UTI) in women–a systematic review and meta-analysis. J. Chemother. 34(3), 139–148 (2022).
  MedlineGoogle Scholar
• 4. Czajkowski K, Broś-Konopielko M, Teliga-Czajkowska J. Urinary tract infection in women. PM 20(1), 40–47 (2021).
  CASGoogle Scholar
• 5. Zhu H, Chen Y, Hang Y et al. Impact of inappropriate empirical antibiotic treatment on clinical outcomes of urinary tract infections caused by Escherichia coli: a retrospective cohort study. J. Glob. Antimicrob. Resist. 26, 148–153 (2021).
  Medline CASGoogle Scholar
• 6. Basu S, Mukherjee SK, Hazra A, Mukherjee M. Molecular characterization of uropathogenic Escherichia coli: nalidixic acid and ciprofloxacin resistance, virulent factors and phylogenetic background. JCDR 7(12), 2727–2731 (2013).
  Medline CASGoogle Scholar
• 7. Mukherjee M, Koley S, Mukherjee SK, Basu S, Ghosh B, Chakraborty S. Phylogenetic background of E. coli isolated from asymptomatic pregnant women from Kolkata, India. J. Infect. Dev. Ctries 9(07), 720–724 (2015).
  Medline CASGoogle Scholar
• 8. Ballesteros-Monrreal MG, Arenas-Hernández MM, Enciso-Martínez Y et al. Virulence and resistance determinants of uropathogenic Escherichia coli strains isolated from pregnant and non-pregnant women from two states in Mexico. IDR 13, 295–310 (2020). • Discrete virulence gene distribution was reported in this study from pregnant and nonpregnant populations.
  CASGoogle Scholar
• 9. M Taha Aloob H. Molecular characterization of multi drug resistance Escherichia coli isolated among diabetes mellitus patients in Dongla State, Sudan. AJBSR 9(5), 357–363 (2020).
  Google Scholar
• 10. Terlizzi ME, Gribaudo G, Maffei ME. UroPathogenic Escherichia coli (UPEC) infections: virulence factors, bladder responses, antibiotic, and non-antibiotic antimicrobial strategies. Front. Microbiol. 8, 1566 (2017).
  MedlineGoogle Scholar
• 11. Spencer JD, Schwaderer AL, Becknell B, Watson J, Hains DS. The innate immune response during urinary tract infection and pyelonephritis. Pediatr. Nephrol. 29(7), 1139–1149 (2014).
  MedlineGoogle Scholar
• 12. Nagamatsu K, Hannan TJ, Guest RL et al. Dysregulation of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infection. Proc. Natl Acad. Sci. USA 112(8), E871–E880 (2015).
  Medline CASGoogle Scholar
• 13. Waldhuber A, Puthia M, Wieser A et al. Uropathogenic Escherichia coli strain CFT073 disrupts NLRP3 inflammasome activation. J. Clin. Invest. 126(7), 2425–2436 (2016).
  MedlineGoogle Scholar
• 14. Demirel I, Persson A, Brauner A, Särndahl E, Kruse R, Persson K. Activation of the NLRP3 inflammasome pathway by uropathogenic Escherichia coli is virulence factor-dependent and influences colonization of bladder epithelial cells. Front. Cell. Infect. Microbiol. 8, 81 (2018).
  MedlineGoogle Scholar
• 15. Ambite I, Puthia M, Nagy K et al. Molecular basis of acute cystitis reveals susceptibility genes and immunotherapeutic targets. PLOS Pathog. 12(10), e1005848 (2016).
  MedlineGoogle Scholar
• 16. Sundac L, Dando SJ, Sullivan MJ, Derrington P, Gerrard J, Ulett GC. Protein-based profiling of the immune response to uropathogenic Escherichia coli in adult patients immediately following hospital admission for acute cystitis. Pathog. Dis. 74(6), ftw062 (2016).
  MedlineGoogle Scholar
• 17. Engelsöy U, Rangel I, Demirel I. Impact of proinflammatory cytokines on the virulence of uropathogenic Escherichia coli. Front. Microbiol. 10, 1051 (2019). •• This study investigated the impact of proinflammatory cytokines (TNF-α, IL-1β, IL-6, IL-8 and IFN-γ) on the virulence of uropathogenic Escherichia coli (UPEC) prototype strain CFT073.
  MedlineGoogle Scholar
• 18. Jung J-H, Hong HJ, Gharderpour A et al. Differential interleukin-1β induction by uropathogenic Escherichia coli correlates with its phylotype and serum C-reactive protein levels in Korean infants. Sci. Rep. 9(1), doi: 10.1038/s41598-019-52070-3 (2019). •• This study revealed that IL1β production in infected hosts was dependent on hemolysin and cytotoxic necrotizing factors of the invading UPEC.
  Google Scholar
• 19. Chu CM, Lowder JL. Diagnosis and treatment of urinary tract infections across age groups. Am. J. Obstet. Gynecol. 219(1), 40–51 (2018).
  MedlineGoogle Scholar
• 20. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing (30th edition). CLSI supplement M100, PA, USA (2020).
  Google Scholar
• 21. Vega-Hernández R, Ochoa SA, Valle-Rios R et al. Flagella, Type I fimbriae and curli of uropathogenic Escherichia coli promote the release of proinflammatory cytokines in a coculture system. Microorganisms 9(11), 2233 (2021).
  Medline CASGoogle Scholar
• 22. Stork C, Kovács B, Rózsai B et al. Characterization of asymptomatic bacteriuria Escherichia coli isolates in search of alternative strains for efficient bacterial interference against uropathogens. Front. Microbiol. 9, 214 (2018).
  MedlineGoogle Scholar
• 23. Ho C-H, Fan C-K, Yu H-J et al. Testosterone suppresses uropathogenic Escherichia coli invasion and colonization within prostate cells and inhibits inflammatory responses through JAK/STAT-1 signaling pathway. PLOS ONE 12(6), e0180244 (2017).
  MedlineGoogle Scholar
• 24. Monroy-Pérez E, Cerón AB, García Cortés LR et al. Virulence gene transcription, phylogroups, and antibiotic resistance of cervico-vaginal pathogenic E. coli in Mexico. PLOS ONE 15(6), e0234730 (2020).
  Medline CASGoogle Scholar
• 25. Bandyopadhyay D, Mukherjee M. Reactive oxygen species and uspA overexpession: an alternative bacterial response toward selection and maintenance of multidrug resistance in clinical isolates of uropathogenic E. coli. Eur. J. Clin. Microbiol. Infect. Dis. 39(9), 1753–1760 (2020).
  Medline CASGoogle Scholar
• 26. Yadav S. Correlation analysis in biological studies. J. Pract. Cardiovasc. Sci. 4(2), 116 (2018).
  Google Scholar
• 27. Ghosh A, Bandyopadhyay D, Koley S, Mukherjee M. Uropathogenic Escherichia coli in India – an overview on recent research advancements and trends. Appl. Biochem. Biotechnol. 193(7), 2267–2296 (2021).
  Medline CASGoogle Scholar
• 28. Bachchan KT, Ramanujan SS. Prevalence of multidrug resistant asymptomatic bacteriuria from pregnant and non-pregnant women in the Erode district. Int. J. Biochem. Biotechnol. 5(3), 665–669 (2016).
  CASGoogle Scholar
• 29. Paniagua-Contreras GL, Monroy-Pérez E, Rodríguez-Moctezuma JR, Domínguez-Trejo P, Vaca-Paniagua F, Vaca S. Virulence factors, antibiotic resistance phenotypes and O-serogroups of Escherichia coli strains isolated from community-acquired urinary tract infection patients in Mexico. J. Microbiol. Immunol. Infect. 50(4), 478–485 (2017).
  MedlineGoogle Scholar
• 30. Ramírez-Castillo FY, Moreno-Flores AC, Avelar-González FJ, Márquez-Díaz F, Harel J, Guerrero-Barrera AL. An evaluation of multidrug-resistant Escherichia coli isolates in urinary tract infections from Aguascalientes, Mexico: cross-sectional study. Ann. Clin. Microbiol. Antimicrob. 17(1), 34 (2018).
  MedlineGoogle Scholar
• 31. Abate D, Marami D, Letta S. Prevalence, antimicrobial susceptibility pattern, and associated factors of urinary tract infections among pregnant and nonpregnant women at public health facilities, Harar, Eastern Ethiopia: a comparative cross-sectional study. Can. J. Infect. Dis. Med. Microbiol. 2020, 9356865 (2020).
  MedlineGoogle Scholar
• 32. Asmat U, Mumtaz MZ, Malik A. Rising prevalence of multidrug-resistant uropathogenic bacteria from urinary tract infections in pregnant women. J. Taibah Univ. Med. Sci. 16(1), 102–111 (2021).
  MedlineGoogle Scholar
• 33. Ali AH, Reda DY, Ormago MD. Prevalence and antimicrobial susceptibility pattern of urinary tract infection among pregnant women attending Hargeisa Group Hospital, Hargeisa, Somaliland. Sci. Rep. 12(1), 1419 (2022).
  Medline CASGoogle Scholar
• 34. Yun KW, Kim HY, Park HK, Kim W, Lim IS. Virulence factors of uropathogenic Escherichia coli of urinary tract infections and asymptomatic bacteriuria in children. J. Microbiol. Immunol. Infect. 47(6), 455–461 (2014).
  Medline CASGoogle Scholar
• 35. Rahdar M, Rashki A, Miri HR, Rashki Ghalehnoo M. Detection of pap, sfa, afa, foc, and fim adhesin-encoding operons in uropathogenic Escherichia coli isolates collected from patients with urinary tract infection. Jundishapur J. Microbiol. 8 (8), e22647 (2015).
  MedlineGoogle Scholar
• 36. Lee JH, Subhadra B, Son Y-J et al. Phylogenetic group distributions, virulence factors and antimicrobial resistance properties of uropathogenic Escherichia coli strains isolated from patients with urinary tract infections in South Korea. Lett. Appl. Microbiol. 62(1), 84–90 (2016).
  Medline CASGoogle Scholar
• 37. Tabasi M. Genotypic characterization of virulence factors in Escherichia coli isolated from patients with acute cystitis, pyelonephritis and asymptomatic bacteriuria. JCDR 10(12), DC01–DC07 (2016).
  MedlineGoogle Scholar
• 38. Munkhdelger Y, Gunregjav N, Dorjpurev A, Juniichiro N, Sarantuya J. Detection of virulence genes, phylogenetic group and antibiotic resistance of uropathogenic Escherichia coli in Mongolia. J. Infect. Dev. Ctries 11(01), 51–57 (2017).
  Medline CASGoogle Scholar
• 39. Ali I, Rafaque Z, Ahmed I et al. Phylogeny, sequence-typing and virulence profile of uropathogenic Escherichia coli (UPEC) strains from Pakistan. BMC Infect. Dis. 19(1), 620 (2019).
  MedlineGoogle Scholar
• 40. Cristea VC, Gheorghe I, Czobor Barbu I et al. Snapshot of phylogenetic groups, virulence, and resistance markers in Escherichia coli uropathogenic strains isolated from outpatients with urinary tract infections in Bucharest, Romania. BioMed Res. Intl 2019, 5712371 (2019).
  MedlineGoogle Scholar
• 41. Dadi BR, Abebe T, Zhang L, Mihret A, Abebe W, Amogne W. Distribution of virulence genes and phylogenetics of uropathogenic Escherichia coli among urinary tract infection patients in Addis Ababa, Ethiopia. BMC Infect. Dis. 20(1), 108 (2020).
  Medline CASGoogle Scholar
• 42. Rezatofighi SE, Mirzarazi M, Salehi M. Virulence genes and phylogenetic groups of uropathogenic Escherichia coli isolates from patients with urinary tract infection and uninfected control subjects: a case-control study. BMC Infect. Dis. 21(1), 361 (2021).
  Medline CASGoogle Scholar
• 43. Al-Zubaidi SJJ. Prevalence of virulence factors genes of Escherichia coli isolated from pregnant and non-pregnant women with urinary tract infection in Diyala Iraq. Syst. Rev. Pharm. 11(6), 1420–1427 (2020).
  Google Scholar
• 44. Lee S, Yu JK, Park K, Oh E-J, Kim S-Y, Park Y-J. Phylogenetic groups and virulence factors in pathogenic and commensal strains of Escherichia coli and their association with blaCTX-M. Ann. Clin. Lab. Sci. 40(4), 361–367 (2010).
  MedlineGoogle Scholar
• 45. Tarchouna M, Ferjani A, Ben-Selma W, Boukadida J. Distribution of uropathogenic virulence genes in Escherichia coli isolated from patients with urinary tract infection. Intl J. Infect. Dis. 17(6), e450–e453 (2013).
  Medline CASGoogle Scholar
• 46. Alabsi MS, Ghazal A, Sabry SA, Alasaly MM. Association of some virulence genes with antibiotic resistance among uropathogenic Escherichia coli isolated from urinary tract infection patients in Alexandria, Egypt: a hospital-based study. J. Glob. Antimicrob. Resist. 2(2), 83–86 (2014).
  MedlineGoogle Scholar
• 47. Dhakal BK, Mulvey MA. The UPEC pore-forming toxin α-hemolysin triggers proteolysis of host proteins to disrupt cell adhesion, inflammatory, and survival pathways. Cell Host Microbe 11(1), 58–69 (2012). •• This study showed that HlyA-induced proteolysis of host proteins likely allow UPEC to suppress inflammatory responses in the host.
  Medline CASGoogle Scholar
• 48. Moeinizadeh H, Shaheli M. Frequency of hlyA, hlyB, hlyC and hlyD genes in uropathogenic Escherichia coli isolated from UTI patients in Shiraz. GMS Hyg. Infect. Control 16, Doc25 (2021).
  MedlineGoogle Scholar
• 49. Karimian A, Momtaz H, MahbobeMadani M. Detection of uropathogenic Escherichia coli virulence factors in patients with urinary tract infection in Iran. Afr. J. Microbiol. Res. 6(39), 6811–6816 (2012).
  Google Scholar
• 50. Reygaert WC. Innate immune response to urinary tract infections involving Escherichia coli. J. Clin. Cell Immunol. 5(6), doi: 10.4172/2155-9899.1000280 (2014).
  Google Scholar
• 51. Roos V, Ulett GC, Schembri MA, Klemm P. The asymptomatic bacteriuria Escherichia coli strain 83972 outcompetes uropathogenic E. coli strains in human urine. Infect. Immun. 74(1), 615–624 (2006).
  Medline CASGoogle Scholar
• 52. Hernández JG, Sundén F, Connolly J, Svanborg C, Wullt B. Correction: genetic control of the variable innate immune response to asymptomatic bacteriuria. PLOS ONE 7(1), doi: 10.1371/annotation/ab823a8e-01b1-48b8-8b2a-0993d805fc50 (2012).
  Google Scholar
• 53. Kalita A, Hu J, Torres AG. Recent advances in adherence and invasion of pathogenic Escherichia coli. Curr. Opin. Infect. Dis. 27(5), 459–464 (2014).
  MedlineGoogle Scholar
• 54. Frömmel U, Lehmann W, Rödiger S et al. Adhesion of human and animal Escherichia coli strains in association with their virulence-associated genes and phylogenetic origins. Appl. Environ. Microbiol. 79(19), 5814–5829 (2013).
  MedlineGoogle Scholar
• 55. Shah C, Baral R, Bartaula B, Shrestha LB. Virulence factors of uropathogenic Escherichia coli (UPEC) and correlation with antimicrobial resistance. BMC Microbiol. 19(1), 204 (2019). • This study established a significant association between virulence factors of UPEC and their antimicrobial resistance pattern. The highest resistance toward ampicillin, cotrimoxazole and norfloxacin was also reported.
  MedlineGoogle Scholar
• 56. Snyder JA, Haugen BJ, Buckles EL et al. Transcriptome of uropathogenic Escherichia coli during urinary tract infection. Infect. Immun. 72(11), 6373–6381 (2004). •• In this study, transcriptomic analysis of Escherichia coli prototype strain CFT073 isolated from infected CBA/J mice was reported.
  Medline CASGoogle Scholar
• 57. Melican K, Sandoval RM, Kader A et al. Uropathogenic Escherichia coli P and Type 1 fimbriae act in synergy in a living host to facilitate renal colonization leading to nephron obstruction. PLoS Pathog. 7(2), e1001298 (2011).
  Medline CASGoogle Scholar
• 58. Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat. Rev. Microbiol. 13(5), 269–284 (2015).
  Medline CASGoogle Scholar
• 59. Stocks CJ, Phan M-D, Achard MES et al. Uropathogenic Escherichia coli employs both evasion and resistance to subvert innate immune-mediated zinc toxicity for dissemination. Proc. Natl Acad. Sci. USA 116(13), 6341–6350 (2019).
  Medline CASGoogle Scholar
• 60. Kim A, Ahn JH, Choi WS et al. What is the cause of recurrent urinary tract infection? Contemporary microscopic concepts of pathophysiology. Int. Neurourol. J. 25(3), 192–201 (2021).
  MedlineGoogle Scholar
• 61. Prasanphanich NS, Gregory EJ, Erickson JJ, Miller-Handley H, Kinder JM, Way SS. Preconceptual priming overrides susceptibility to Escherichia coli systemic infection during pregnancy. mBio 12(1), e00002–00021 (2021).
  Medline CASGoogle Scholar
• 62. Parameswaran N, Patial S. Tumor necrosis factor-α signaling in macrophages. Crit. Rev. Eukar. Gene Expr. 20(2), 87–103 (2010).
  Medline CASGoogle Scholar
• 63. Schütze S, Kaufmann A, Bunkowski S, Ribes S, Nau R. Interferon-gamma impairs phagocytosis of Escherichia coli by primary murine peritoneal macrophages stimulated with LPS and differentially modulates proinflammatory cytokine release. Cytokine X 3(3), doi: 10.1016/j.cytox.2021.100057 (2021). •• This study concluded that elevated levels of IFN-γ might lead to reduced bacterial clearance in aged individuals.
  MedlineGoogle Scholar
• 64. Steiner SE, Choong FX, Antypas H et al. UPEC kidney infection triggers neuro-immune communication leading to modulation of local renal inflammation by splenic IFNγ. PLoS Pathog. 17(5), e1009553 (2021).
  Medline CASGoogle Scholar
• 65. Brauner A, Söderhäll M, Jacobson SH, Lundahl J, Andersson U, Andersson J. Escherichia coli-induced expression of IL-1 α IL-1 β IL-6 and IL-8 in normal human renal tubular epithelial cells. Clin. Exp. Immunol. 124(3), 423–428 (2001).
  Medline CASGoogle Scholar
• 66. Chamoun MN, Sullivan MJ, Goh KGK et al. Restriction of chronic Escherichia coli urinary tract infection depends upon T cell-derived interleukin-17, a deficiency of which predisposes to flagella-driven bacterial persistence. FASEB J. 34(11), 14572–14587 (2020). •• This study showed that deficiency in production of IL-17A contributed to bacterial persistence.
  Medline CASGoogle Scholar
• 67. O'Brien VP, Dorsey DA, Hannan TJ, Hultgren SJ. Host restriction of Escherichia coli recurrent urinary tract infection occurs in a bacterial strain-specific manner. PLoS Pathog. 14(12), e1007457 (2018).
  MedlineGoogle Scholar
• 68. Gilbert NM, O'Brien VP, Waller C, Batourina E, Mendelsohn CL, Lewis AL. Gardnerella exposures alter bladder gene expression and augment uropathogenic Escherichia coli urinary tract infection in mice. Front. Cell. Infect. Microbiol. 12, doi: 10.3389/fcimb.2022.909799 (2022).
  Google Scholar
• 69. Juang J, Yin H, Zhang C, Wang J. Effects of E. coli infection on the expressions of TGF-β/Smads signaling pathway in broiler intestine. Braz. J. Poult. Sci. 22(1), doi: 10.1590/1806-9061-2019-1101 (2020).
  Google Scholar
• 70. Ljungberg JK, Kling JC, Tran TT, Blumenthal A. Functions of the WNT signaling network in shaping host responses to infection. Front. Immunol. 10, 2521 (2019).
  Medline CASGoogle Scholar
• 71. Jafari NV, Rohn JL. The urothelium: a multi-faceted barrier against a harsh environment. Mucosal Immunol. 15, 1127–1142 (2022).
  Medline CASGoogle Scholar